NASDAQ:VCYT - Veracyte News Headlines

$27.57
-0.36 (-1.29 %)
(As of 06/16/2019 04:00 PM ET)
Today's Range
$27.38
Now: $27.57
$28.25
50-Day Range
$22.35
MA: $24.34
$27.76
52-Week Range
$8.48
Now: $27.57
$28.25
Volume325,195 shs
Average Volume675,827 shs
Market Capitalization$1.15 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.88

Headlines

Veracyte (NASDAQ VCYT) News Headlines

Source:
DateHeadline
7 Top-Rated Biotech Stocks to Invest In Today7 Top-Rated Biotech Stocks to Invest In Today
investorplace.com - June 14 at 3:01 PM
Insider Selling: Veracyte Inc (NASDAQ:VCYT) Chairman Sells 8,000 Shares of StockInsider Selling: Veracyte Inc (NASDAQ:VCYT) Chairman Sells 8,000 Shares of Stock
www.americanbankingnews.com - June 11 at 5:53 PM
Veracyte Inc (NASDAQ:VCYT) Receives Consensus Recommendation of "Buy" from BrokeragesVeracyte Inc (NASDAQ:VCYT) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 11 at 8:47 AM
Veracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer DiagnosisVeracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis
finance.yahoo.com - June 10 at 5:40 PM
Riskalyze hires Bay Area tech executive as CFORiskalyze hires Bay Area tech executive as CFO
finance.yahoo.com - June 7 at 5:29 PM
Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with DiagnosisVeracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis
finance.yahoo.com - June 1 at 4:51 PM
Veracyte Inc (VCYT) Expected to Post Quarterly Sales of $29.20 MillionVeracyte Inc (VCYT) Expected to Post Quarterly Sales of $29.20 Million
www.americanbankingnews.com - May 31 at 3:46 AM
Before You Buy Veracyte, Inc. (NASDAQ:VCYT), Consider Its VolatilityBefore You Buy Veracyte, Inc. (NASDAQ:VCYT), Consider Its Volatility
finance.yahoo.com - May 30 at 5:45 PM
Veracyte Announces Participation in Two Upcoming Investor ConferencesVeracyte Announces Participation in Two Upcoming Investor Conferences
finance.yahoo.com - May 29 at 6:03 PM
 Brokerages Expect Veracyte Inc (VCYT) Will Post Earnings of -$0.09 Per Share Brokerages Expect Veracyte Inc (VCYT) Will Post Earnings of -$0.09 Per Share
www.americanbankingnews.com - May 29 at 8:11 AM
Veracyte Announces New Data Demonstrating Afirma Xpression Atlass Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting - Business WireVeracyte Announces New Data Demonstrating Afirma Xpression Atlas's Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting - Business Wire
www.businesswire.com - May 23 at 9:29 AM
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual MeetingVeracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting
finance.yahoo.com - May 23 at 9:29 AM
Veracyte (VCYT) Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis - StreetInsider.comVeracyte (VCYT) Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis - StreetInsider.com
www.streetinsider.com - May 20 at 12:27 PM
Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology - Yahoo FinanceVeracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology - Yahoo Finance
finance.yahoo.com - May 14 at 9:47 AM
Veracyte Names Sangeeta Bhorade, M.D., Medical Director of PulmonologyVeracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology
finance.yahoo.com - May 14 at 9:47 AM
Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT)Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT)
finance.yahoo.com - May 11 at 4:54 PM
Veracyte to Present at the UBS Global Healthcare Conference - Yahoo FinanceVeracyte to Present at the UBS Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - May 9 at 6:32 PM
Veracyte to Present at the UBS Global Healthcare ConferenceVeracyte to Present at the UBS Global Healthcare Conference
finance.yahoo.com - May 9 at 6:32 PM
These 3 revolutionary genomics companies are changing lives for patients — and investors - MarketWatchThese 3 revolutionary genomics companies are changing lives for patients — and investors - MarketWatch
www.marketwatch.com - May 9 at 9:30 AM
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo FinanceVeracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo Finance
finance.yahoo.com - May 7 at 6:04 PM
The Daily Biotech Pulse: FDA Nod For Sanofis Dengue Vaccine, Veracyte Offering, Biogen Reports Positive DataThe Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data
www.msn.com - May 4 at 9:37 AM
Veracyte prices stock offering at $23.25Veracyte prices stock offering at $23.25
seekingalpha.com - May 4 at 9:37 AM
Form S-3ASR VERACYTE, INC. - StreetInsider.comForm S-3ASR VERACYTE, INC. - StreetInsider.com
www.streetinsider.com - May 3 at 9:38 AM
Veracyte (VCYT) Prices 5.5M Share Offering at $23.25/Sh - StreetInsider.comVeracyte (VCYT) Prices 5.5M Share Offering at $23.25/Sh - StreetInsider.com
www.streetinsider.com - May 3 at 9:38 AM
Veracyte: 1Q Earnings Snapshot - Yahoo FinanceVeracyte: 1Q Earnings Snapshot - Yahoo Finance
finance.yahoo.com - May 1 at 6:23 PM
Veracyte Announces Proposed Public Offering of Common Stock - Yahoo FinanceVeracyte Announces Proposed Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - May 1 at 6:23 PM
Veracyte up 13% on Q1 beat, improved revenue outlook - Seeking AlphaVeracyte up 13% on Q1 beat, improved revenue outlook - Seeking Alpha
seekingalpha.com - May 1 at 6:23 PM
Veracyte, Inc. 2019 Q1 - Results - Earnings Call Slides - Seeking AlphaVeracyte, Inc. 2019 Q1 - Results - Earnings Call Slides - Seeking Alpha
seekingalpha.com - May 1 at 6:23 PM
Veracytes (VCYT) CEO Bonnie Anderson on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaVeracyte's (VCYT) CEO Bonnie Anderson on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 1 at 9:18 AM
Edited Transcript of VCYT earnings conference call or presentation 30-Apr-19 9:00pm GMTEdited Transcript of VCYT earnings conference call or presentation 30-Apr-19 9:00pm GMT
finance.yahoo.com - May 1 at 9:18 AM
Veracyte (VCYT) Tops Q1 EPS by 5c, Revenues Beat; Raises FY19 Revenue Guidance Above Consensus - StreetInsider.comVeracyte (VCYT) Tops Q1 EPS by 5c, Revenues Beat; Raises FY19 Revenue Guidance Above Consensus - StreetInsider.com
www.streetinsider.com - April 30 at 5:59 PM
Veracyte, Inc. to Host Earnings Call - Yahoo FinanceVeracyte, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - April 30 at 5:59 PM
Veracyte, Inc. to Host Earnings CallVeracyte, Inc. to Host Earnings Call
finance.yahoo.com - April 30 at 5:59 PM
Veracyte Announces First Quarter 2019 Financial ResultsVeracyte Announces First Quarter 2019 Financial Results
finance.yahoo.com - April 30 at 5:59 PM
Form 8-K VERACYTE, INC. For: Apr 26 - StreetInsider.comForm 8-K VERACYTE, INC. For: Apr 26 - StreetInsider.com
www.streetinsider.com - April 26 at 6:05 PM
Veracyte (VCYT) Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State - StreetInsider.comVeracyte (VCYT) Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State - StreetInsider.com
www.streetinsider.com - April 22 at 5:21 PM
Veracyte Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York StateVeracyte Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State
finance.yahoo.com - April 22 at 5:21 PM
Veracyte Names Alfred Bowie, Jr., Ph.D. as Vice President, Corporate and Business DevelopmentVeracyte Names Alfred Bowie, Jr., Ph.D. as Vice President, Corporate and Business Development
finance.yahoo.com - April 22 at 9:17 AM
Can You Imagine How Chuffed Veracyte's (NASDAQ:VCYT) Shareholders Feel About Its 297% Share Price Gain?Can You Imagine How Chuffed Veracyte's (NASDAQ:VCYT) Shareholders Feel About Its 297% Share Price Gain?
finance.yahoo.com - April 19 at 5:56 PM
Veracyte (VCYT) Announces Publication Highlighting Afirma GSCs Ability to Rule Out Cancer in Thyroid Nodule Subtype - StreetInsider.comVeracyte (VCYT) Announces Publication Highlighting Afirma GSC's Ability to Rule Out Cancer in Thyroid Nodule Subtype - StreetInsider.com
www.streetinsider.com - April 8 at 11:51 AM
Veracyte Announces Publication Highlighting Afirma GSC’s Ability to Rule Out Cancer in Challenging Thyroid Nodule SubtypeVeracyte Announces Publication Highlighting Afirma GSC’s Ability to Rule Out Cancer in Challenging Thyroid Nodule Subtype
finance.yahoo.com - April 8 at 11:51 AM
Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019 - Business WireVeracyte to Release First Quarter 2019 Financial Results on April 30, 2019 - Business Wire
www.businesswire.com - April 3 at 10:47 AM
Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF - Business WireVeracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF - Business Wire
www.businesswire.com - April 3 at 10:47 AM
Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019
finance.yahoo.com - April 3 at 10:47 AM
Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPFVeracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF
finance.yahoo.com - April 2 at 11:04 AM
Veracyte Announces Participation in the 18th Annual Needham Healthcare ConferenceVeracyte Announces Participation in the 18th Annual Needham Healthcare Conference
finance.yahoo.com - March 28 at 6:11 PM
Research Report Identifies Alamos Gold, Thermo Fisher Scientific, Veracyte, Air Lease, Carlisle Companies, and Medidata Solutions with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement - GlobeNewswireResearch Report Identifies Alamos Gold, Thermo Fisher Scientific, Veracyte, Air Lease, Carlisle Companies, and Medidata Solutions with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement - GlobeNewswire
www.globenewswire.com - March 27 at 9:53 AM
Veracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer - Business WireVeracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer - Business Wire
www.businesswire.com - March 26 at 9:41 AM
Veracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid CancerVeracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer
finance.yahoo.com - March 25 at 6:23 PM
Will Veracyte Continue to Surge Higher?Will Veracyte Continue to Surge Higher?
finance.yahoo.com - March 22 at 6:13 PM
This page was last updated on 6/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel